[PDF][PDF] Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2

…, G Ye, X Luo, F Wang, JC Ang, A Zganiacz… - Cell, 2022 - cell.com
The emerging SARS-CoV-2 variants of concern (VOCs) threaten the effectiveness of current
COVID-19 vaccines administered intramuscularly and designed to only target the spike …

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

…, M Santosuosso, K Huygen, A Zganiacz… - The Journal of …, 2004 - journals.aai.org
Bacillus Calmette-Guérin (BCG) vaccine has failed to control the global tuberculosis (TB)
epidemic, and there is a lack of safe and effective mucosal vaccines capable of potent …

[HTML][HTML] Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut–lung axis

…, MR D'Agostino, Y Yao, S Jain, A Zganiacz… - Nature …, 2022 - nature.com
Aside from centrally induced trained immunity in the bone marrow (BM) and peripheral
blood by parenteral vaccination or infection, evidence indicates that mucosal-resident innate …

[HTML][HTML] TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection

A Zganiacz, M Santosuosso, J Wang… - The Journal of …, 2004 - Am Soc Clin Investig
TNF-α has long been regarded as a proimmune cytokine involved in antimicrobial type 1
immunity. However, the precise role of TNF-α in antimicrobial type 1 immunity remains poorly …

A human type 5 adenovirus–based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity

…, MF Medina, N Thanthrige-Don, A Zganiacz… - Science translational …, 2013 - science.org
There is an urgent need to develop new tuberculosis (TB) vaccines to safely and effectively
boost Bacille Calmette-Guérin (BCG)–triggered T cell immunity in humans. AdHu5Ag85A is a …

Intranasal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances Protection by Parenteral Mycobacterium bovis BCG Immunization against Pulmonary …

…, S McCormick, X Zhang, A Zganiacz… - Infection and …, 2006 - Am Soc Microbiol
Parenterally administered Mycobacterium bovis BCG vaccine confers only limited immune
protection from pulmonary tuberculosis in humans. There is a need for developing effective …

Single Intranasal Mucosal Mycobacterium bovis BCG Vaccination Confers Improved Protection Compared to Subcutaneous Vaccination against Pulmonary …

L Chen, J Wang, A Zganiacz, Z Xing - Infection and immunity, 2004 - Am Soc Microbiol
Whether the intranasal (in) route of Mycobacterium bovis BCG vaccination provides better
protection against pulmonary tuberculosis than subcutaneous (sc) vaccination remains an …

[HTML][HTML] Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans

…, DK Fritz, S Afkhami, E Aguirre, KJ Howie, A Zganiacz… - JCI insight, 2022 - ncbi.nlm.nih.gov
Background Adenovirus-vectored (Ad-vectored) vaccines are typically administered via im
injection to humans and are incapable of inducing respiratory mucosal immunity. However, …

[HTML][HTML] Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection

…, K Kugathasan, CL Small, A Zganiacz… - The American journal of …, 2011 - Elsevier
Lung immunopathology is the main cause of influenza-mediated morbidity and death, and
much of its molecular mechanisms remain unclear. Whereas tumor necrosis factor-α (TNF-α) …

Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-α and nitric oxide from macrophages via IFN …

Z Xing, A Zganiacz… - Journal of leukocyte …, 2000 - academic.oup.com
IL-12 is believed to play an important role in cell-mediated immunity against intracellular
infection primarily by acting on T and NK cells. Recent evidence has suggested, however, that IL…